Tugas Telaan Kritis Artikel Penelitian - Intra Arterial Heparin Flushing Increases Manual Muscle Test Medical Research Councils - Gea Pandhita S

May 26, 2018 | Author: Gea Pandhita S | Category: N/A
Share Embed Donate


Short Description

Telaah Kritis Artikel Terapi...

Description

!"#$% !'($$) *+,!,% $+!,*'( -'.'(,!,$. #/0 -0123450 %

67278 $954:/8 -/1/845401; ,.!+$ $+!'+,$( )'-$+,. "%=(' !'%! ? >'@,=$( +'%'$+=) =A".=,(% B>>!C>+=D %=A+' ,. =)+A.,= ,%=)'>,= %!+A*' -$!,'.! !/90E01 $F7G -759015HIJKJ ,90E01 L7G7M IJ N0O35409 >795080IJ $124 P4Q0R0I "#$%&'() *+ ,-./%/0-1

2$3$0&../0 40/5-63/()1 ,$7$33$6890.*0-3/$ :;$(*( 6?) @-0(6$' 2*3A/($'1 B$7$6($890.*0-3/$1 B'C >=.&' D$E?$0 2# (6-$(?-0( =-%*?- OV1:U K@9 QRS 2# (6-$(?-0(C IE-6/3 $ 3/H0/+/%$0( ./++-6-0%- =-(W--0 A6- $0. A*3( 9>2# (6-$(?-0( /0 @E6*0/% 93%E-?/% X$(/-0( KAYP1PRLC

"

 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 1 '$2*3 &) 4"&." 5-+5/- #(- #//+.#$-* #$ (#)*+, $+ (-.-&6- +)- +7 '-6-(#/ &)$-(6-)$&+)' :C X-0-'/(/$0 (-63-=&( $.$'$E A-0-'/(/$0 ]&$3/ -73A-6/?-0($' *0- H6*&A A6-8 (-3( A*3(8(-3( OC I/.$7 (-6.$A$( 6$0.*? $''*%$(/*0 K6$0.*?/3$3/L A$.$ A-0-'/(/$0 (-63-=&(C GC ^-'-?$E$0 A-0-'/(/$0 ]&$3/ -73A-6/?-0($' *0- H6*&A A6-8(-3( A*3(8(-3( $.$'$E 6-0.$E0)$ 5$'/./($3 /0(-60$'C 6(/7-' A-0-'/(/$0 (/.$7 ?-0)-=&(7$0 =-6$A$ A$3/-0 )$0H ?-0H$'$?/ '*3( (* +*''*W8&A :C T$'$? 3&=8=$= @/G4F1 012 %0VZ8/G  .$0 .$'$? =$=  +'%"(! ./3-=&(7$0 =$EW$ (-6.$A$( UR 3&=_-7 A-0-'/(/$0 )$0H =-6A$6(/3/A$3/ .$'$? A-0-'/(/$0 (-63-=&(C ^-(6$0H$0 /0/ ?-0H/0./7$3/7$0 =$EW$ (/.$7 (-6.$A$( A$3/-0 )$0H ?-0H$'$?/ '*3( (* +*''*W8&AC OC >6(/7-' A-0-'/(/$0 (/.$7 ?-0)-=&(7$0 =-6$A$ '$?$ W$7(& +*''*W8&A 3-(-'$E A-?=-6/$0 (-6$A/1 0$?&0 .$'$? =$= =A.=("%,A.% ./0)$($7$0 =$EW$ A$.$ A-0-'/(/$0 3-'$0_&(0)$ $7$0 ./'$7&7$0 A-0H&7&6$0 *&(%*?3-%$6$ 3-6/$' 3-'$?$ (/H$ =&'$0C

:

`^ P/9/ 088 Z054/15G 0108R_/2 41 53/ F9H7ZG 5H E34O3 53/R E/9/ 9012HV4_/2] +'%"(! UR %E6*0/% /3%E-?/% 3(6*7- A$(/-0(3 W-6- A$6(/%/A$(-. /0 *&6 3(&.)C ,,I 5$'&-3 =-+*6- $0. $+(-6 9>2# (6-$(?-0( W-6- $0$')Z-. &3/0H A$/6-. (8(-3( *HV/1509; "C I/.$7 (-6.$A$( 6$0.*? $''*%$(/*0 K6$0.*?/3$3/L A$.$ A-0-'/(/$0 (-63-=&(C :C X-0-'/(/$0 (-63-=&( $.$'$E A-0-'/(/$0 ]&$3/ -73A-6/?-0($' *0- H6*&A A6-8(-3( A*3(8(-3( OC T$'$? =$=  +'%"(!  ./3-=&(7$0 =$EW$ 7-3-'&6&E$0 3&=_-7 A-0-'/(/$0 )$0H =-6A$6(/3/A$3/ ./$0$'/3/3 .$'$? H6*&A (&0HH$' K=-+*6-8$+(-6L

a^ P/9/ Z054/15G 012 O8414O401G :/Z5 X8412 5H 59/05V/15] *HV/1509; "C X-0-'/(/$0 (-63-=&( $.$'$E A-0-'/(/$0 ]&$3/ -73A-6/?-0($' *0- H6*&A A6-8(-3( A*3(8(-3( :C ^-3-'&6&E$0 3&=_-7 A-0-'/(/$0 ?-0.$A$(7$0 /0(-65-03/ (-6$A/ -73A-6/?-0($' )$0H 3$?$ OC I/.$7 (-6.$A$( ='/0. (* (6-$(?-0(

W^ P/9/ F9H7ZG 59/05/2 /b7088RJ 0Z095 M9HV 53/ /\Z/94V/1508 53/90ZR] *HV/1509; "C X-0-'/(/$0 (-63-=&( $.$'$E A-0-'/(/$0 ]&$3/ -73A-6/?-0($' *0- H6*&A A6-8(-3( A*3(8(-3( :C ^-3-'&6&E$0 3&=_-7 A-0-'/(/$0 ?-0.$A$(7$0 (-6$A/ -73A-6/?-0($' )$0H 3$?$1 0$?&0 (/.$7 ./_-'$37$0 $A$7$E 3&=_-7 A-0-'/(/$0 ?-0.$A$(7$0 (-6$A/ '$/0 3-'$/0 (-6$A/ -73A-6/?-0($' (-63-=&(1 .$0 $A$7$E (-6$A/ '$/0 (-63-=&( 3$?$ &0(&7 3-(/$A A$3/-0C T^ P/9/ 53/ F9H7ZG G4V4809 05 53/ G5095 HM 53/ 59408] *HV/1509; "C >6(/7-' A-0-'/(/$0 (/.$7 ?-0$?A/'7$0 7$6$7(-6/3(/7 .$3$6 3&=_-7 A-0-'/(/$0 3-%$6$ _-'$3 :C X-0-'/(/$0 (-63-=&( $.$'$E A-0-'/(/$0 ]&$3/ -73A-6/?-0($' *0- H6*&A A6-8(-3( A*3(8(-3(

O

 $9/ 53/ [0842 9/G785G HM 534G 4124[42708 G572R 4VZH95015] c^ P305 4G 53/ V0F14572/ HM 53/ 59/05V/15 /MM/O5] +'%"(! I$='- "C IE- T/++-6-0%- *+ ,,I X6- $0. X*3( 9>2# (6-$(?-0(C

`- +*&0. (E$( ,,I 3%*6- ?-$0 5$'&- /0%6-$3-. OP1:" K@9 QRS 6(/7-' A-0-'/(/$0 (/.$7 ?-0$?A/'7$0 3-%$6$ _-'$3 =$H$/?$0$ %$6$ A-0H&7&6$0 *&(%*?- 3-E/0HH$ ./A-6*'-E $0H7$ ,,I8,D@ 3-A-6(/ (-63-=&( ./ $($3 K?/3$'b $A$7$E A-0H&7&6$0 ./'$7&7$0 A$.$ -73(6-?/($3 $($31 $($& -73(6-?/($3 =$W$Ec >A$7$E 0/'$/ (-63-=&( ?-6&A$7$0 A-0_&?'$E$0 .$6/ 7-.&$ -73(6-?/($3cL GC >6(/7-' A-0-'/(/$0 _&H$ (/.$7 ?-0_-'$37$0 3-%$6$ .-($/' (-67$/( $3A-7 5$'/./($3 .$0 6-'/$=/'/($3 A-0H&7&6$0 ,,I8,D@

d^ )HE Z9/O4G/ 4G 534G /G54V05/ HM 53/ 59/05V/15 /MM/O5] +'%"(! I$='- "C IE- T/++-6-0%- *+ ,,I X6- $0. X*3( 9>2# (6-$(?-0(C

*HV/1509;

G

"C F/'$/ QRS @9 &0(&7 ,,I A6-89>2# $.$'$E 3-7/($6 $0($6$ :U1UQ8O:1VO :C F/'$/ QRS @9 &0(&7 ,,I A*3(89>2# $.$'$E 3-7/($6 $0($6$ OO1RQ8O\1QR

 $9/ 53/ [0842J 4VZH95015 9/G785G HM 534G 4124[42708 G572R 0ZZ84O0X8/ 5H H79 Z054/15] Y^ ,G H79 Z054/15 GH 24MM/9/15 M9HV 53HG/ 41 53/ G572R 5305 45G 9/G785G O011H5 0ZZ8R *HV/1509; "C >6(/7-' A-0-'/(/$0 (/.$7 ?-0$?A/'7$0 7$6$7(-6/3(/7 .$3$6 3&=_-7 A-0-'/(/$0 3-%$6$ _-'$31 3-E/0HH$ =-'&? .$A$( ./7-($E&/ 7-3-3&$/$0 $0($6$ 3&=_-7 A-0-'/(/$0 .-0H$0 A$3/-0 ./ 6&?$E 3$7/( '$/0 :C >6(/7-' A-0-'/(/$0 (/.$7 ?-0$?A/'7$0 76/(-6/$ 3&=_-7 )$0H _-'$31 3-E/0HH$ 7-?&0H7/0$0 (-6.$A$( 7-6$H$?$0 A$3/-0 .$'$? E$' 7-A$6$E$0 7'/0/31 (/0H7$( 7-A$6$E$0 $($& A-6'&$3$0 '-3/ /0+$67 ./ *($71 .''C OC >6(/7-' A-0-'/(/$0 (/.$7 ?-0_-'$37$0 3-%$6$ .-($/' (-0($0H 76/(-6/$ 3(6*7/37-?/7 76*0/31 7E&3&30)$ (-67$/( =-6$A$ '$?$ A-6/*.- W$7(& 3-(-'$E *03-(1 A$.$ ?$3/0H8?$3/0H 3&=_-7C
View more...

Comments

Copyright ©2017 KUPDF Inc.
SUPPORT KUPDF